On the other hand, the involvement of obesity in IR prevents IGF-1 from binding to insulin receptors on osteoblasts, leading to dysfunctional insulin signaling, which negatively affects bone remodeling48–50. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.